{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-167A",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-167A.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "regulation/167A",
  "kind": "regulation",
  "number": "167A",
  "heading": "NIMAR supply to Northern Ireland",
  "text": "(1) If the following conditions are met—\n(a) the prohibitions in regulation 46 (requirement for authorisation) do not apply in relation to a medicinal product sold or supplied, or offered for sale or supply, in Northern Ireland, and\n(b) that product is classified in Northern Ireland as a prescription only medicine.\n(2) Condition A is that a UK marketing authorisation of a following type is in force for the product—\n(a) a UKMA(UK);\n(b) a UKMA(GB).\n(3) Condition B is that the product is classified as a prescription only medicine in accordance with regulation 5(3) for the purposes of sale and supply in Great Britain.\n(4) Condition C is that the product is a listed NIMAR product.\n(5) Condition D is that if the product is to be distributed by wholesale dealing by a person (“P”) in Northern Ireland, P must be a holder of a wholesale dealer’s licence.\n(6) Condition E is that if the product is manufactured or assembled in Great Britain, it is supplied to Northern Ireland—\n(a) by the holder of a manufacturer’s licence in respect of that product; or\n(b) by the holder of a wholesale dealer’s licence.\n(7) Condition F is that if the product is manufactured outside of the UK and imported into Great Britain, it is supplied to Northern Ireland—\n(a) by a holder of a manufacturer’s licence in respect of that product; or\n(b) by the holder of a wholesale dealer’s licence.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Regs. 167A, 167B inserted (1.1.2022) by The Human Medicines (Amendment) (Supply to Northern Ireland) Regulations 2021 (S.I. 2021/1452), regs. 1(2), 14"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/regulation/167A",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}